Physician profile
Judith Mckenzie
NPI 1215902887
$980.54
in general payments reported to CMS, 2019-2025
13 companies · $87.42 in 2025
The $87.42 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.85 · 2020: $19.36 · 2021: $189 · 2022: $313 · 2023: $145 · 2024: $209 · 2025: $87.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.90 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $354.44 | 2021-2025 | |
| Abbott Laboratories | $212.69 | 2021-2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $136.58 | 2021-2024 | Arexvy |
| Dexcom, INC. | $47.33 | 2023-2024 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $47.16 | 2021 | |
| Inspire Medical Systems, INC. | $39.08 | 2025 | Inspire |
| Atricure, INC. | $26.13 | 2023 | |
| Novo Nordisk INC | $25.32 | 2021-2022 | |
| Dynavax Technologies Corporation | $19.36 | 2020 | |
| Amgen INC. | $19.23 | 2021 | |
| Boston Scientific Corporation | $18.85 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.85 | 2025 | Jardiance |
| Pfizer INC. | $15.52 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.